Heme biosynthesis is a vital biochemical process that produces heme, an iron-containing compound essential for various biological functions, including oxygen transport and electron transfer.

Recent research has focused on understanding the complex systems involved in heme biosynthesis and the maturation of cytochrome c, particularly in bacteria and eukaryotes. This research is ...

Bitopertin is an investigational, clinical-stage, orally administered inhibitor of glycine transporter 1 (GlyT1) that is designed to modulate heme biosynthesis. GlyT1 is a membrane transporter ...

X-linked sideroblastic anemia (XLSA) is a rare genetic disorder caused by mutations in the ALAS2 gene, which plays a critical role in heme biosynthesis within red blood cells.

About Bitopertin Bitopertin is an investigational, clinical-stage, orally administered inhibitor of glycine transporter 1 (GlyT1) that is designed to modulate heme biosynthesis. GlyT1 is a membrane ...

Bitopertin is an investigational, clinical-stage, orally administered inhibitor of glycine transporter 1 (GlyT1) that is designed to modulate heme biosynthesis. GlyT1 is a membrane transporter ...

Disc Medicine, Inc. (NASDAQ:IRON – Get Free Report) has been assigned an average rating of “Buy” from the ten ratings firms ...

We are building a portfolio of innovative, potentially first-in-class therapeutic candidates that aim to address a wide spectrum of hematologic diseases by targeting fundamental biological pathways of ...

Stock analysts at Cantor Fitzgerald issued their FY2025 earnings per share estimates for Disc Medicine in a research note issued to investors on Tuesday, January 21st. Cantor Fitzgerald analyst K.

Cautionary Statement Regarding Forward-Looking Statements ...